Related Experiment Video
Updated: Nov 20, 2025
10:21
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
3.3K
De Novo Prediction of Drug-Target Interactions Using Laplacian Regularized Schatten -Norm Minimization
Gaoyan Wu1, Mengyun Yang2, Yaohang Li3
1The Hunan Provincial Key Lab of Bioinformatics, School of Computer Science and Engineering, Central South University, Changsha, China.
Summary
This study introduces a new computational algorithm to predict drug-target interactions (DTIs), accelerating drug discovery. The method aims to reduce the time and cost of experimental validation for potential DTIs.
Area of Science:
- Pharmaceutical Sciences
- Computational Biology
- Bioinformatics
Background:
- Identifying drug-target interactions (DTIs) is vital in drug discovery.
- Experimental validation of DTIs is costly, time-consuming, and labor-intensive.
- Computational methods are needed to predict potential DTIs efficiently.
Purpose of the Study:
- To propose a novel computational algorithm for predicting drug-target interactions (DTIs).
- To guide experimental verification and accelerate the drug discovery process, particularly in de novo situations.
Main Methods:
- Development of a new algorithm named Laplacian regularized Schatten.
- Application of computational approaches to predict potential DTIs.
Main Results:
- The proposed algorithm offers a more efficient approach to DTI prediction.
- The method aids in prioritizing DTIs for experimental validation.
Conclusions:
- The developed Laplacian regularized Schatten algorithm is a significant advancement in computational drug discovery.
- This approach can reduce the resources required for identifying novel drug-target interactions.
Related Concept Videos
02:04Protein-protein Interfaces
14.2K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.2K
01:30Quantitative Aspects of Drug-Receptor Interaction
1.5K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.5K
02:40Ligand Binding Sites
14.5K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.5K
01:29Drug-Receptor Interactions
6.9K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.9K
01:28Structure-Activity Relationships and Drug Design
1.4K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.4K
01:49Conserved Binding Sites
4.8K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.8K